Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Corticosteroid"

Article category

Keywords

Publication year

"Corticosteroid"

Case Reports

Viral hepatitis

Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang
Clin Mol Hepatol 2018;24(4):430-435.
Published online November 27, 2017
DOI: https://doi.org/10.3350/cmh.2017.0016
Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.

Citations

Citations to this article as recorded by  Crossref logo
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies
    Parag Jain, Akanksha Jain, Rohitas Deshmukh, Pradeep Samal, Trilochan Satapathy, Ajazuddin
    Clinics and Research in Hepatology and Gastroenterology.2025; 49(6): 102584.     CrossRef
  • Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure
    He Wang, Yu Qian, Jing-Wen Wang, Yu Fang, Yu-Chen Fan, Hui-Hui Liu, Kai Wang
    International Health.2023; 15(1): 19.     CrossRef
  • Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care
    Cyriac Abby Philips, Kamna Kakkar, Moby Joseph, Praveen Kumar Yerol, Rizwan Ahamed, Sasidharan Rajesh, Philip Augustine
    Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
  • 13,010 View
  • 262 Download
  • 3 Web of Science
  • Crossref

Drug induced liver injury

Drug-induced liver injury caused by iodine-131
Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le, Jin Woo Lee
Clin Mol Hepatol 2016;22(2):272-275.
Published online May 20, 2016
DOI: https://doi.org/10.3350/cmh.2015.0037
Iodine-131 is a radioisotope that is routinely used for the treatment of differentiated thyroid cancer after total or near-total thyroidectomy. However, there is some evidence that iodine-131 can induce liver injury . Here we report a rare case of drug-induced liver injury (DILI) caused by iodine-131 in a patient with regional lymph node metastasis after total thyroidectomy. A 47-year-old woman was admitted with elevated liver enzymes and symptoms of general weakness and nausea. Ten weeks earlier she had undergone a total thyroidectomy for papillary thyroid carcinoma and had subsequently been prescribed levothyroxine to reduce the level of thyroid-stimulating hormone. Eight weeks after surgery she underwent iodine-131 ablative therapy at a dose of 100 millicuries, and subsequently presented with acute hepatitis after 10 days. To rule out all possible causative factors, abdominal ultrasonography, endoscopic ultrasonography (on the biliary tree and gall bladder), and a liver biopsy were performed. DILI caused by iodine-131 was suspected. Oral prednisolone was started at 30 mg/day, to which the patient responded well.

Citations

Citations to this article as recorded by  Crossref logo
  • Protective Role of Vitamin D in Attenuating RAI-Induced Liver Injury in Rats
    Muzaffer Atli, Aylin Akbulut, Serdar Kuru, Nadide Koca, Koray Demirel, Gökhan Koca, Mehmet Şeneş, Nihat Yumuşak, Meliha Korkmaz
    Bratislava Medical Journal.2025;[Epub]     CrossRef
  • Hepatotoxicity of iodine-131 ablation for post-surgical differentiated thyroid cancer patients with hepatitis B virus infection
    Zhishuo Mo, Ziying Lei, Peipei Wang, Zhebin Wu, Haijuan Yuan, Dongying Xie, Zeqian Wu, Zenan Huang
    Clinics and Research in Hepatology and Gastroenterology.2021; 45(6): 101631.     CrossRef
  • Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review
    Baimei Zeng, Ling Yuan, Jun Chu, Yanqing Yang, Shide Lin
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • The interplay between thyroid and liver: implications for clinical practice
    E. Piantanida, S. Ippolito, D. Gallo, E. Masiello, P. Premoli, C. Cusini, S. Rosetti, J. Sabatino, S. Segato, F. Trimarchi, L. Bartalena, M. L. Tanda
    Journal of Endocrinological Investigation.2020; 43(7): 885.     CrossRef
  • Perioperative considerations of hyperthyroidism in a patient with liver failure: case report
    Byung Hwa Kim, Yun Hee Kim, Yoon Sook Lee, Woon Young Kim, Jae Hwan Kim
    Medical Biological Science and Engineering.2019; 2(2): 60.     CrossRef
  • Recent Advances in the Histopathology of Drug-Induced Liver Injury
    David E. Kleiner
    Surgical Pathology Clinics.2018; 11(2): 297.     CrossRef
  • Iodine-131

    Reactions Weekly.2016; 1617(1): 140.     CrossRef
  • 16,103 View
  • 153 Download
  • 4 Web of Science
  • Crossref

Review

Alcohol-related liver disease

Managing alcoholic liver disease
Vijay H. Shah
Clin Mol Hepatol 2015;21(3):212-219.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.212

Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the setting of alcoholic hepatitis. Despite a large number of recent treatment trials, the ideal pharmacotherapy approach remains undefined. Most essential is the supportive care and focus on abstinence and nutrition. Owing in part to a great deal of attention from governmental funding sources, a number of new treatment approaches are undergoing rigorous evaluation, hopefully providing future treatment options in this very severe condition.

Citations

Citations to this article as recorded by  Crossref logo
  • New perspective on fecal microbiota transplantation in liver diseases
    Ki Tae Suk, Hong Koh
    Journal of Gastroenterology and Hepatology.2022; 37(1): 24.     CrossRef
  • Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study
    Ha Il Kim, Seo Young Park, Hyun Phil Shin
    Scientific Reports.2021;[Epub]     CrossRef
  • Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Meegun Hong, Dae Hee Han, Jitaek Hong, Dong Joon Kim, Ki Tae Suk
    Probiotics and Antimicrobial Proteins.2019; 11(2): 335.     CrossRef
  • Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study
    Won Kim, Dongjae Jeong, Jungwha Chung, Donghyeon Lee, Saekyoung Joo, Eun Sun Jang, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
    Scientific Reports.2019;[Epub]     CrossRef
  • Growing burden of alcoholic liver disease in China: A review
    Wen-Jun Wang, Peng Xiao, Hong-Qin Xu, Jun-Qi Niu, Yan-Hang Gao
    World Journal of Gastroenterology.2019; 25(12): 1445.     CrossRef
  • Effect of Taurine on Ethanol-Induced Oxidative Stress in Mouse Liver and Kidney
    Zofia Goc, Edyta Kapusta, Grzegorz Formicki, Monika Martiniaková, Radoslav Omelka
    Chinese Journal of Physiology.2019; 62(4): 148.     CrossRef
  • Liver Fibrosis: A Clinical Update
    Lindsey C. Shipley, Page D. Axley, Ashwani K. Singal
    EMJ Hepatology.2019; : 105.     CrossRef
  • Role of liver transplantation in severe alcoholic hepatitis
    Ravi Daswani, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora
    Clinical and Molecular Hepatology.2018; 24(1): 43.     CrossRef
  • Epidemiology of alcoholic liver disease in Korea
    Jae Young Jang, Dong Joon Kim
    Clinical and Molecular Hepatology.2018; 24(2): 93.     CrossRef
  • CX3CR1 differentiates F4/80low monocytes into pro-inflammatory F4/80high macrophages in the liver
    Young-Sun Lee, Myung-Ho Kim, Hyon-Seung Yi, So Yeon Kim, Hee-Hoon Kim, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun, Jin-Seok Byun, Won-Il Jeong
    Scientific Reports.2018;[Epub]     CrossRef
  • Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary care
    Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin
    PLOS ONE.2018; 13(12): e0208798.     CrossRef
  • Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature
    Lisa Humbertjean-Selton, Jérôme Selton, Nolwenn Riou-Comte, Jean-Christophe Lacour, Gioia Mione, Sébastien Richard
    Clinical and Molecular Hepatology.2018; 24(4): 417.     CrossRef
  • Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy
    Young-Sun Lee, Hyun Jung Kim, Ji Hoon Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Jae Seon Kim, Jong-Jae Park, Soon Ho Um, Young-Tae Bak, Kwan So
    Journal of Clinical Gastroenterology.2017; 51(4): 364.     CrossRef
  • Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
    Suk Kyun Hong, Nam-Joon Yi, Hyo-Sin Kim, Sung Woo Ahn, Kyung Chul Yoon, Hyeyoung Kim, Kwang-Woong Lee, Kyung-Suk Suh
    Journal of Korean Medical Science.2017; 32(6): 919.     CrossRef
  • 13,036 View
  • 260 Download
  • 14 Web of Science
  • Crossref
Case Report
Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases
Eileen L. Yoon, Hyung Joon Yim, Seung Young Kim, Jeong Han Kim, Ju-Han Lee, Young Sun Lee, Hyun Jung Lee, Sung Woo Jung, Sang Woo Lee, Jai Hyun Choi
Korean J Hepatol 2010;16(3):329-333.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.329

Acute hepatitis A is currently outbreaking in Korea. Although prognosis of acute hepatitis A is generally favorable, a minority of patients are accompanied by fatal complications. Severe cholestasis is one of the important causes of prolonged hospitalization in patients with acute hepatitis A. In such cases, higher chances of additional complications and increased medical costs are inevitable. We report three cases of severely cholestatic hepatitis A, who showed favorable responses to oral corticosteroids. Thirty milligram of prednisolone was initiated and tapered according to the responses. Rapid improvement was observed in all cases without side effects. We suggest that corticosteroid administration can be useful in hepatitis A patients with severe cholestasis who do not show improvement by conservative managements. Clinical trial will be needed to evaluate effectiveness of corticosteroids in these patients.

Citations

Citations to this article as recorded by  Crossref logo
  • Prolonged cholestatic jaundice as an atypical manifestation of acute hepatitis A virus (HAV) infection in children: Case reports
    MdShafiul Alam, Md Benzamin, Shariful Hasan, Nadia Haq, MdWahiduzzaman Mazumdar
    Paediatric Nephrology Journal of Bangladesh.2021; 6(1): 56.     CrossRef
  • Atypical presentations of hepatitis A infection in children
    Sayma Rahman Munmun, Archana Shrestha Yadav, Mohammad Benzamin, Abu Sayed Mohammad Bazlul Karim, Mohammad Rukunuzzaman, Mohammad Wahiduzzaman Mazumder, Suborna Rani Das
    Paediatrica Indonesiana.2021; 61(6): 317.     CrossRef
  • Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients
    Daad Daghman, Mohamad Saeed Rez, Amjad Soltany, Almotaman Alsaleh
    Oxford Medical Case Reports.2019;[Epub]     CrossRef
  • Adrenal Insufficiency Associated with Cholestatic Jaundice: A Case Report
    Wei-Cheng Lee, Shou-Chuan Shih, Horng-Yuan Wang, Chien-Liang Wu, Shih-Yi Lee, Hui-Chun Ku
    International Journal of Gerontology.2018; 12(2): 164.     CrossRef
  • Current opinion in epidemiology and approaches to the treatment of viral hepatitis A and E.
    Matúš Mihalčin, Lenka Fašaneková, Petr Husa, Petr Husa
    Klinická farmakologie a farmacie.2017; 31(1): 15.     CrossRef
  • Viral hepatitis A - possible diagnostic and therapeutic problems
    Petr Husa, Petr Husa
    Vnitřní lékařství.2017; 63(7-8): 498.     CrossRef
  • High prevalence of gallbladder involvement during hepatitis: An outbreak in a paediatric population
    S Vita, G Tebano, A M Rossomando, Rosa A De, E N Cavallari, E Caraffa, C Ajassa, V Vullo
    Journal of Medical Laboratory and Diagnosis.2016; 7(1): 1.     CrossRef
  • 9,421 View
  • 89 Download
  • Crossref